Associate Professor, Internal Medicine, University of Utah Sch of Med

Hematology

Dr. Djordje Atanackovic, MD

Djordje Atanackovic is an expert in the field of Hematology. Djordje Atanackovic, MD is also published. He has 3 publications published. The lastest publication: "Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.' He accepts Medicare payments and is listed with Medicare.gov.

Publications

Chimeric Antigen Receptor (CAR) therapy for multiple Myeloma.
Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and Myeloma-propagating pre-plasma cells in the bone marrow of multiple Myeloma patients.
Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4(+) and CD8(+) T-cell responses in multiple Myeloma patients.

Conditions Treated

Myeloma

Doctors Specialties

Hematology

Accepted Insurances

Hospital

University of Utah Health Care - Hospital and Clinics

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1417384694
Last Name Of The Provider	ATANACKOVIC
First Name Of The Provider	DJORDJE
View All

Similar Doctors

	Dr. Wei Song, MD This Doctor is OpenDoctor Recommended.
	Dr. James P. Kushner, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David W. Bahler, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Melissa H. Cessna, MD
	Dr. Ann T. Taylor, MD
	Dr. Ronald L. Weiss, MD
	Dr. Conan G. Kinsey, MD
	Dr. Tian Y. Zhang, MD
	Dr. Jay L. Patel, MD
	Dr. John H. Ward, MD This Doctor is OpenDoctor Recommended.